GlassScriptPhysician profile
Jasmine Gause
NPI 1861936213
$541.04
in general payments reported to CMS, 2019-2025
10 companies · $72.69 in 2025
The $72.69 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $84.22 · 2022: $213 · 2023: $86.68 · 2024: $84.58 · 2025: $72.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $204.67 | 2022-2024 | Micra |
| Abbott Laboratories | $77.89 | 2021-2023 | Cardiomems |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $76.45 | 2021-2025 | Relistor |
| Redhill Biopharma INC. | $44.90 | 2021-2022 | |
| Inari Medical, INC. | $43.80 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Vertex Pharmaceuticals Incorporated | $25.43 | 2025 | |
| Valinor Pharma, LLC | $22.96 | 2025 | Movantik |
| Azurity Pharmaceuticals, INC. | $18.72 | 2024 | Horizant |
| Janssen Pharmaceuticals, INC | $14.13 | 2021 | |
| Virtus Pharmaceuticals LLC | $12.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasmine Gause listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.